CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax

Katharina Mattes; Mylène Gerritsen; Hendrik Folkerts; Marjan Geugien; Fiona A van den Heuvel; Arthur Flohr Svendsen; Guoqiang Yi; Joost H A Martens; Edo Vellenga

doi:10.3324/haematol.2019.229997

CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax

Katharina Mattes, Mylène Gerritsen, Hendrik Folkerts, Marjan Geugien, Fiona A van den Heuvel, Arthur Flohr Svendsen, Guoqiang Yi, Joost H A Martens, Edo Vellenga^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

72 Downloads (Pure)

Original language	English
Pages (from-to)	e399-e403
Number of pages	5
Journal	Haematologica
Volume	105
Issue number	8
Early online date	14-Nov-2019
DOIs	https://doi.org/10.3324/haematol.2019.229997
Publication status	Published - 1-Aug-2020

Keywords

RESISTANCE

Access to Document

10.3324/haematol.2019.229997

CD34+ Acute Myeloid Leukemia Cells With Low Levels Of Reactive Oxygen Species Show Increased Expression Of Stemness Genes And Can Be Targeted By The BCL2 Inhibitor VenetoclaxFinal publisher's version, 1.6 MBLicence: Taverne

Handle.net

Persistent link

Cite this

Mattes, K., Gerritsen, M., Folkerts, H., Geugien, M., van den Heuvel, F. A., Flohr Svendsen, A., Yi, G., Martens, J. H. A., & Vellenga, E. (2020). CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax. Haematologica, 105(8), e399-e403. Advance online publication. https://doi.org/10.3324/haematol.2019.229997

@article{602c915ad3724340844631f386f5e1ed,

title = "CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax",

keywords = "RESISTANCE",

author = "Katharina Mattes and Myl{\`e}ne Gerritsen and Hendrik Folkerts and Marjan Geugien and {van den Heuvel}, {Fiona A} and {Flohr Svendsen}, Arthur and Guoqiang Yi and Martens, {Joost H A} and Edo Vellenga",

year = "2020",

month = aug,

day = "1",

doi = "10.3324/haematol.2019.229997",

language = "English",

volume = "105",

pages = "e399--e403",

journal = "Haematologica",

issn = "0390-6078",

publisher = "FERRATA STORTI FOUNDATION",

number = "8",

}

Mattes, K, Gerritsen, M, Folkerts, H, Geugien, M, van den Heuvel, FA, Flohr Svendsen, A, Yi, G, Martens, JHA & Vellenga, E 2020, 'CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax', Haematologica, vol. 105, no. 8, pp. e399-e403. https://doi.org/10.3324/haematol.2019.229997

CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax. / Mattes, Katharina; Gerritsen, Mylène; Folkerts, Hendrik et al.
In: Haematologica, Vol. 105, No. 8, 01.08.2020, p. e399-e403.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax

AU - Mattes, Katharina

AU - Gerritsen, Mylène

AU - Folkerts, Hendrik

AU - Geugien, Marjan

AU - van den Heuvel, Fiona A

AU - Flohr Svendsen, Arthur

AU - Yi, Guoqiang

AU - Martens, Joost H A

AU - Vellenga, Edo

PY - 2020/8/1

Y1 - 2020/8/1

KW - RESISTANCE

U2 - 10.3324/haematol.2019.229997

DO - 10.3324/haematol.2019.229997

M3 - Article

C2 - 31727766

SN - 0390-6078

VL - 105

SP - e399-e403

JO - Haematologica

JF - Haematologica

IS - 8

ER -